Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefan Faderl
Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The Role of Combined Fludarabine, Cyclophosphamide and Rituximab Chemoimmunotherapy in Chronic Lymphocytic Leukemia: Current Evidence and Controversies
Therapeutic Advances in Hematology
Hematology
Assessment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma by Absolute Lymphocyte Counts in 2,126 Patients: 20 Years of Experience at the University of Texas M.D. Anderson Cancer Center
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Resveratrol Blocks Interleukin-1 -Induced Activation of the Nuclear Transcription Factor NF- B, Inhibits Proliferation, Causes S-Phase Arrest, and Induces Apoptosis of Acute Myeloid Leukemia Cells
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy
Cancer
Cancer Research
Oncology
Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
Cancer
Cancer Research
Oncology
‹
1
2
